Cargando…

Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality

Selective serotonin reuptake inhibitors (SSRI) are the most common antidepressant used by pregnant women; however, they have been associated with adverse pregnancy outcomes and perinatal morbidity in pregnant women and animal models. We investigated the effects of two SSRI, fluoxetine and sertraline...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domingues, Rafael R., Fricke, Hannah P., Sheftel, Celeste M., Bell, Autumn M., Sartori, Luma C., Manuel, Robbie S. J., Krajco, Chandler J., Wiltbank, Milo C., Hernandez, Laura L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780128/ https://www.ncbi.nlm.nih.gov/pubmed/35051053 http://dx.doi.org/10.3390/toxics10010011

Ejemplares similares

Pregnancy Complications and Neonatal Mortality in a Serotonin Transporter Null Mouse Model: Insight Into the Use of Selective Serotonin Reuptake Inhibitor During Pregnancy
por: Domingues, Rafael R., et al.
Publicado: (2022)

MON-001 Peripartum Sertraline (Zoloft®) Increases Pup Mortality Immediately Postpartum
por: Sheftel, Celeste, et al.
Publicado: (2020)

Fluoxetine Administration During Lactation Impacts the Bone Health of the Dam and the Offspring in Mice
por: Fricke, Hannah P, et al.
Publicado: (2021)

SAT-020 Fluoxetine Administration Influences Serotonin-Driven Bone Remodeling During Lactation and Pregnancy Outcome in Mice
por: Fricke, Hannah P, et al.
Publicado: (2020)

THU403 Fluoxetine Administration During The Peripartal Period And The Effect On Calcium Metabolism And Serotonin Signaling In The Mammary Gland
por: Fricke, Hannah, et al.
Publicado: (2023)

Peripartal treatment with low‐dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone
por: Sheftel, Celeste M., et al.
Publicado: (2022)

SAT-009 SSRI Use in the Peripartum Period Regulates Mammary Gland Parathyroid Hormone Related Protein (PTHrP) by a Serotonylation-Dependent Mechanism
por: Sheftel, Celeste, et al.
Publicado: (2020)

Serotonin Reuptake Inhibitors in Pregnancy: Can Genes Help Us in Predicting Neonatal Adverse Outcome?
por: Giudici, Valentina, et al.
Publicado: (2014)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2017)

Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
por: Vignato, Julie A., et al.
Publicado: (2022)

The antidepressant fluoxetine (Prozac(®)) modulates estrogen signaling in the uterus and alters estrous cycles in mice
por: Domingues, Rafael R., et al.
Publicado: (2023)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition
por: Westin, Andreas Austgulen, et al.
Publicado: (2018)

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
por: Poweleit, Ethan A., et al.
Publicado: (2022)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
por: Pedersen, Lars Henning, et al.
Publicado: (2009)

Gestational Exposure to Serotonin Reuptake Inhibitors and Pregnancy Outcome; Exploring the Role of Bias and Confounders
por: Koren, Gideon, et al.
Publicado: (2021)

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Takata, Junko, et al.
Publicado: (2019)

Is pregnancy loss initiated by embryonic death or luteal regression? Profiles of pregnancy-associated glycoproteins during elevated progesterone and pregnancy loss
por: Domingues, Rafael R., et al.
Publicado: (2022)

Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation
por: Sheftel, Celeste M., et al.
Publicado: (2020)

Effect of Serotonin Reuptake Inhibitors on Pulmonary Hemodynamics in Humans
por: Pleym, Hilde, et al.
Publicado: (2011)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Trajectories of Depressive and Anxiety Symptoms Across Pregnancy and Postpartum in Selective Serotonin Reuptake Inhibitor‐Treated Women
por: Mesches, Gabrielle A., et al.
Publicado: (2022)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
por: Marks, David M, et al.
Publicado: (2009)

Transient Serotonin Syndrome Caused by Concurrent Use of Tramadol and Selective Serotonin Reuptake Inhibitor
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2014)

Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval
por: Reed, M.B., et al.
Publicado: (2021)

Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021)

The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials
por: Azizi, Marzieh, et al.
Publicado: (2022)

Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors
por: Cosci, Fiammetta, et al.
Publicado: (2022)

Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity
por: Vahid-Ansari, Faranak, et al.
Publicado: (2019)

RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
por: Singh, A.N., et al.
Publicado: (2000)

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis
por: Kornum, Jette B, et al.
Publicado: (2010)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_61cjbdnp5f971764h1jp08stfk